DNA损伤诱导的亡抑制剂通过增强淋巴细胞增强剂-结合因子1的表达来触发瘤的进展和干部
You Lin Chen1,2, Yi Liu3,2, Yan Xu4
1Department of Neurosurgery, the First People's Hospital of Yibin, Yibin, Sichuan 644000, China.
由DNA损伤诱导的亡抑制剂 (DDIAS) 通过上调淋巴细胞增强剂结合因子1 (LEF1) 来促进质瘤的进展和干性. 准DDIAS可能为质瘤治疗提供了一个新的治疗策略.
科学领域:
- 神经瘤学神经瘤学
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- DNA损伤诱导的亡抑制剂 (DDIAS) 与癌症进展有关.
- DDIAS在质瘤中的特定作用和机制在很大程度上仍未被描述.
研究的目的:
- 研究DDIAS在质瘤进展中的作用和调控机制.
- 探索DDIAS作为质瘤的潜在治疗点.
主要方法:
- 使用GEPIA和GENT2数据库对质瘤组织进行DDIAS表达分析.
- 在体外和体外模型中使用DDIAS淘汰 (shRNA) 的功能研究.
- RNA测序以确定下游效应因子和调节途径.
- 试验包括细胞活力 (CCK-8),增殖 (EdU),入侵,迁移和瘤球体形成.
主要成果:
- DDIAS在质瘤中高度表达,与预后不佳相关.
- DDIAS knockdown抑制了质瘤细胞的活力,增殖,入侵,迁移和瘤生长.
- 淋巴细胞增强剂结合因子1 (LEF1) 被确定为DDIAS的一个关键下游效应因子.
- 通过DDIAS下调诱导的LEF1过度表达拯救了表型,包括干性标记物 (CD133) 和细胞周期调节物 (循环A1).
结论:
- 通过诱导LEF1.1,DDIAS促进了结质瘤的进展和干性.
- DDIAS代表了质瘤治疗的潜在治疗点.
更多相关视频
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
相关概念视频
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
DNA Damage can Stall the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Extrinsic Apoptotic Pathway
